Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Sienna Biopharmaceuticals, Inc. (SNNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/11/2019 8-K Quarterly results
11/15/2019 8-K Quarterly results
10/17/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Notice of Final Order (I) Establishing Notice and Hearing Procedures for Trading of Sienna Equity Securities and (II) Granting Related Relief"
09/23/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Notice of Order"
09/17/2019 8-K Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation unde...
06/03/2019 8-K Submission of Matters to a Vote of Security Holders
05/08/2019 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals Reports First Quarter 2019 Financial Results"
03/21/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/14/2019 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results"
02/22/2019 8-K Quarterly results
02/08/2019 8-K Quarterly results
01/29/2019 8-K Quarterly results
01/02/2019 8-K Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits
Docs: "Corporate Presentation"
12/12/2018 8-K Other Events
Docs: "FORM 8-K"
12/03/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Sienna Biopharmaceuticals Announces Its Topical, Non-Steroidal TrkA Inhibitor SNA-120 Demonstrated Significant Impact on Psoriasis in Phase 2b Study and Plans to Initiate Phase 3 Psoriasis Trials in Second Half of 2019",
"Presentation"
11/08/2018 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals ® Reports Third Quarter 2018 Financial Results"
10/03/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SIGNATURES"
08/27/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "SIGNATURES",
"Sienna Biopharmaceuticals Announces Results from First-in-Human Study of SNA-125 in Psoriasis and Continued Progression to Phase 2"
08/09/2018 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals Reports Second Quarter 2018 Financial Results"
08/02/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SIGNATURES"
07/30/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "SIGNATURES",
"Sienna Biopharmaceuticals Announces Pivotal Trials with SNA-001 in Acne Did Not Meet Primary and Secondary Endpoints",
"Presentation"
07/24/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "FORM 8-K",
"Sienna Biopharmaceuticals Successfully Completes Maximal Use Safety Study of SNA-120 in Patients with Itch Associated with Psoriasis"
07/02/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan and Security Agreement, between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc",
"Loan and Security Agreement, between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc"
06/07/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Corporate Presentation",
"Corporate Presentation"
06/05/2018 8-K Quarterly results
05/14/2018 8-K Quarterly results
03/15/2018 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results — Pipeline Includes Five Clinical-Stage Programs — Data from Five Clinical Programs Expected, Beginning in 2H18"
02/02/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/27/2017 8-K Unregistered Sales of Equity Securities
11/09/2017 8-K Quarterly results
Docs: "Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results"
09/07/2017 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy